secwatch.observer — SEC 8-K summary
======================================

Issuer:     Opus Genetics, Inc. (IRD)
CIK:        0001228627
Form:       8-K
Filed at:   2023-06-09T23:59:59+00:00
Accession:  0001140361-23-029009
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Ocuphire Pharma shareholders elect six directors, ratify auditor, and approve annual say-on-pay vote
--------------------------------------------------------------------------------

- All six director nominees elected: Cam Gallagher, Sean Ainsworth, James Manuso, Richard Rodgers, Susan Benton, Jay Pepose.
- Ratification of Ernst & Young as auditor passed with 11,172,192 votes for (99.8% of shares voted).
- Advisory vote on frequency of say-on-pay: 'every year' received 4,180,454 votes, board adopts annual frequency.
- Approximately 53.60% of outstanding shares represented at meeting (11,228,343 shares).
- Broker non-votes of 5,087,873 shares noted for director elections.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1228627/000114036123029009/0001140361-23-029009-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1228627/000114036123029009/brhc20054226_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-23-029009

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer